Home page > Communicable diseases and health threats


Please find all related articles below.

Environmental pollution: Neglected dimension of AMR

On 10 December 2015, EPHA and Health Care Without Harm Europe organised an event that discussed the link between AMR and environmental pollution, focusing on antibiotics manufacturing and animal husbandry. The event established that all stakeholders - in particular industry and regulators - must push for enforceable standards and regulation. A new EPHA report further develops this theme. Why is the environment neglected in AMR debates? Despite a number of scandals and growing evidence (...)

World Antibiotic Awareness Week: High time for global policy action

Antimicrobial Resistance (AMR) is a global health threat of unprecented scale and urgency. During the first World Antibiotic Awareness Week (WAAW) from 16-22 November 2015, which encompassed the 8th European Antibiotic Awareness Day (EAAD), emphasis was placed on the global nature of the emergency that requires all institutions and actors to join forces. At the launch event in Brussels, the European Commission, ECDC and WHO sent a clear signal that only effective collaboration can tackle (...)

[Events] Pharma Pollution: An Ignored Cause of Antimicrobial Resistance

Join EPHA, Health Care Without Harm, and MEP hosts Martin Hausling (Greens/EFA) and Jasenko Selimovic (ALDE) to discuss a long-neglected cause of antimicrobial resistance (AMR) - pollution of the natural environment arising from irresponsible antibiotic manufacturing and untransparent global supply chains, as well as from the overuse of antibiotics in veterinary medicine. Speakers will include representatives from civil society, the pharmaceutical industry, as well as EU and international (...)

[Press release] European Antibiotic Awareness Day: Fighting ‘superbugs’ to save lives

Brussels, 18 November – Today marks the 7th European Antibiotic Awareness Day (EAAD) (1) which promotes a more prudent use of antibiotics to tackle the growing challenge of multi-drug resistant ‘superbugs’ (2). Around 25,000 patients die every year in the European Union (EU) as a result of infections caused by antibiotic-resistant bacteria. Preventing the spread of antibiotic resistance will lead to significant health service savings since related costs amount to (...)

Keeping Antimicrobial Resistance (AMR) on the radar screen, year-round

The global problem of Antimicrobial Resistance (AMR) demands the continuous attention of the public health community beyond the annual focus of the European Antibiotic Awareness Day (marked annually on 18 November). EPHA is committed to raising awareness of AMR-related concerns, including the reduction of antibiotics use, to ensure that people living in Europe can continue to benefit from life-saving antibiotics. Moreover, it is important to promote policy coherence, as well as effective, (...)

[EPT] Antimicrobial Resistance (AMR) – EP report: EU-wide plan to tackle the proliferation of AMR (7 November 2013)

Antimicrobial Resistance (AMR) Antimicrobial Resistance (AMR) – EP report - EU-wide plan to tackle the proliferation of AMR Antimicrobial resistance (AMR) has been described as one of the biggest threats to public health - a worrisome development since resistance to drugs designed to treat severe diseases is becoming more widespread. In 2001 the WHO published its Global Strategy for Containment of Antimicrobial Resistance, describing what AMR is and what strategies should be (...)

UK Chief Medical Officer warns of danger of Antimicrobial Resistance

The threat posed by growing antimicrobial resistance (AMR), should be considered as serious as terrorism, according to the UK’s Chief Medical Officer (CMO), Professor Dame Sally Davies. In an interview with the Guardian newspaper, Professor Davies urged the British government to raise the issue at the upcoming G8 Summit and warned that AMR poses a ’catastrophic threat’ to the population. Mirroring comments made by the WHO, she added that, unless concrete steps are taken (...)

‘Innovation in Veterinary Medicines and the Competitiveness of Livestock Farming in the EU’

The event organised by Zoetis (a global animal health company) examined the challenges faced by the animal livestock industry. EPHA attended the meeting to collect and present the key messages of the workshop for EPHA Members. the final Zoetis Workshop Summary report Sandra Beaty from Zoetis stressed that EU legislation should be based on evidences and science. In his presentation Prof. David Leaver, Emeritus Professor The Royal Agricultural College UK, pointed out that if (...)

Consultation for the review of the European policy on organic agriculture

Organic farming and production play a significant economic role in the EU’s agricultural landscape. They can provide a market-oriented alternative for agricultural producers wishing to respond to the increasing demand for high-quality, eco-friendly products. In this consultation, the European Commission would like your views on how organic farming should be best developed. The Public Consultation is available on the website of the European Commission Background - organic farming (...)

European Parliament adopts Resolution on Antimicrobial Resistance

Following an own initiative report by Member of the European Parliament (MEP) Anna Rosbach (ECR, Denmark), the European Parliament voted on 11 December to adopt a resolution on the threat to health posed by Antimicrobial Resistance (AMR). In the resolution, MEPs call for prudent use guidelines to reduce exposure to non-essential antibiotics in human medicine, veterinary practice, agriculture and aquaculture. The text emphasises the need to use antibiotics responsibly, to educate health (...)